ATE293973T1 - Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung zur behandlung von malaria - Google Patents

Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung zur behandlung von malaria

Info

Publication number
ATE293973T1
ATE293973T1 AT95910230T AT95910230T ATE293973T1 AT E293973 T1 ATE293973 T1 AT E293973T1 AT 95910230 T AT95910230 T AT 95910230T AT 95910230 T AT95910230 T AT 95910230T AT E293973 T1 ATE293973 T1 AT E293973T1
Authority
AT
Austria
Prior art keywords
antimalarial
pharmaceutical compositions
compositions containing
alkaloids
malaria
Prior art date
Application number
AT95910230T
Other languages
English (en)
Inventor
Guido Francois
Gerhard Bringmann
J David Phillipson
Michael R Boyd
Laurent Ake Assi
Christoph Schneider
Georges Timperman
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE293973T1 publication Critical patent/ATE293973T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT95910230T 1994-02-14 1995-02-13 Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung zur behandlung von malaria ATE293973T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/195,547 US5639761A (en) 1994-02-14 1994-02-14 Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof
PCT/US1995/001717 WO1995021616A1 (en) 1994-02-14 1995-02-13 Naphthylisoquinoline alkaloids, pharmaceutical compositions containing them and their use for the treatment of malaria

Publications (1)

Publication Number Publication Date
ATE293973T1 true ATE293973T1 (de) 2005-05-15

Family

ID=22721822

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95910230T ATE293973T1 (de) 1994-02-14 1995-02-13 Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung zur behandlung von malaria

Country Status (8)

Country Link
US (2) US5639761A (de)
EP (1) EP0741569B1 (de)
JP (1) JPH10501517A (de)
AT (1) ATE293973T1 (de)
AU (1) AU690967B2 (de)
CA (1) CA2183155C (de)
DE (1) DE69534177T2 (de)
WO (1) WO1995021616A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578729A (en) * 1994-07-22 1996-11-26 The United States Of America As Represented By The Department Of Health And Human Services Dimeric arylisoquinoline alkaloid compounds
US6140339A (en) * 1994-02-14 2000-10-31 The United States Of America As Represented By The Department Of Health And Human Services Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
US5639761A (en) 1994-02-14 1997-06-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof
DK0772595T3 (da) * 1994-07-22 2003-07-21 Us Health Monomerisk og dimerisk naphthylisoquinolinalkaloider og syntesemetoder deraf
CH692321A5 (de) 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
US6143756A (en) * 1998-05-15 2000-11-07 National University Of Singapore Antimalarial activity of β-carboline alkaloids
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
US7108992B2 (en) * 2002-11-27 2006-09-19 St. Jude Children's Research Hospital ATM kinase compositions and methods
DE602004029651D1 (de) * 2003-02-12 2010-12-02 Univ Georgetown Verwendung von artemisinin zur behandlung von durch onkogene viren gebildeten tumoren und zur behandlung von viralen infektionen
WO2007039915A1 (en) 2005-10-04 2007-04-12 The Director General, Defence Research And Development Organisation Anti-malarial compound isolated from gomphostema niveum
WO2007059372A2 (en) * 2005-11-09 2007-05-24 St. Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
WO2012061281A1 (en) 2010-11-04 2012-05-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Diagnostic assays and methods of use for detection of filarial infection
LT2748147T (lt) * 2011-08-25 2017-10-25 St. Jude Children`S Research Hospital 2-alkil-1-okso-n-fenil-3-heteroaril-1,2,3,4-tetrahidroizochinolin-4-karboksamidai, skirti antimaliarinei terapijai
FR3108503A1 (fr) 2020-03-24 2021-10-01 Hermine Lanniel Composition pharmaceutique active contre une infection virale du type coronavirus
WO2022112596A1 (en) 2020-11-30 2022-06-02 Cellectis Sa Use of aminoquinoline compounds for higher gene integration

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH541609A (de) 1970-02-03 1973-09-15 Ciba Geigy Ag Verfahren zur Herstellung von Bi-isochinolinonen und deren Verwendung als Fluoreszenzfarbstoffe in Kunststoffen
US4096190A (en) 1976-11-26 1978-06-20 Ici Americas Inc. Oxidative coupling of alkylphenols catalyzed by metal ammonia complexes
US5001115A (en) * 1989-05-17 1991-03-19 University Of Florida Prodrugs of biologically active hydroxyaromatic compounds
US5025020A (en) * 1989-09-28 1991-06-18 Cancer Biologics Of America, Inc. Use of tetrandrine and its derivatives to treat malaria
EP0594795B1 (de) 1991-04-12 2002-02-13 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
DE4117080A1 (de) * 1991-05-25 1992-11-26 Basf Ag Anwendung von dioncophyllinen als fungizide
WO1994024108A1 (en) 1993-04-19 1994-10-27 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Michellamines useful as antiviral agents
US5552550A (en) 1994-07-22 1996-09-03 The United States Of America, As Represented By The Department Of Health And Human Services Monomeric Naphthylisoquinoline alkaloids and synthesis methods thereof
US5578729A (en) 1994-07-22 1996-11-26 The United States Of America As Represented By The Department Of Health And Human Services Dimeric arylisoquinoline alkaloid compounds
US5571919A (en) 1994-07-22 1996-11-05 The United States Of America As Represented By The Department Of Health And Human Services Dimeric naphthylisoquinoline alkaloids and synthesis methods thereof
US5639761A (en) 1994-02-14 1997-06-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof
US5409938A (en) 1994-02-14 1995-04-25 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof

Also Published As

Publication number Publication date
AU1841795A (en) 1995-08-29
EP0741569A1 (de) 1996-11-13
DE69534177T2 (de) 2006-03-09
EP0741569B1 (de) 2005-04-27
US5639761A (en) 1997-06-17
JPH10501517A (ja) 1998-02-10
AU690967B2 (en) 1998-05-07
WO1995021616A1 (en) 1995-08-17
DE69534177D1 (de) 2005-06-02
CA2183155C (en) 2003-09-09
CA2183155A1 (en) 1995-08-17
US6627641B1 (en) 2003-09-30

Similar Documents

Publication Publication Date Title
ATE293973T1 (de) Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung zur behandlung von malaria
ATE362766T1 (de) Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE60025812D1 (de) Jak-3 hemmer zur behandlung von allergischen störungen
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ATE322265T1 (de) Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält
DE602004032522D1 (de) Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
YU21401A (sh) Tetrahidropiridoetri
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
EP1001782A4 (de) 5,6-HETEROARYL-DIPYRIDO (2-3-b:3',2'-f) AZEPINE UND DEREN VERWENDUNG ZUR PROPHYLAXE UND BEHANDLUNG VON HIV-INFEKTIONEN
ATE198706T1 (de) Polyamin-verbindungen zur behandlung von proliferativer erkrankungen
ATE223917T1 (de) (a)-annelierte pyrrolderivate und deren anwendung in der pharmazie
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
DK0876346T3 (da) Antimalariaaktive quinolinderivater
IL149134A0 (en) Pharmaceutical compositions containing tofisopam
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69635614D1 (de) Verwendung von brefeldin a und deren derivate in der herstellung von arzneimittel zur behandlung von hyperplasie und verwandten erkrankungen
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
ATE339202T1 (de) Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
CA2183247A1 (en) Antimalarial Korupensamines and Pharmaceutical Compositions and Medical Uses Thereof
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
ATE215525T1 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties